Combined Ligand and Fragment-based Drug Design of Selective Histone Deacetylase - 6 Inhibitors
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Combined Ligand and Fragment-based Drug Design of Selective Histone Deacetylase - 6 Inhibitors
Authors
Keywords
-
Journal
Molecular Informatics
Volume -, Issue -, Pages -
Publisher
Wiley
Online
2019-01-11
DOI
10.1002/minf.201800083
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Recent advances in the discovery of potent and selective HDAC6 inhibitors
- (2018) Xiu-Xiu Wang et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Marbostat-100 Defines a New Class of Potent and Selective Antiinflammatory and Antirheumatic Histone Deacetylase 6 Inhibitors
- (2018) Andreas Sellmer et al. JOURNAL OF MEDICINAL CHEMISTRY
- Molecular docking simulations and GRID-independent molecular descriptor (GRIND) analysis to probe stereoselective interactions of CYP3A4 inhibitors
- (2017) Sadia Mukhtar et al. MEDICINAL CHEMISTRY RESEARCH
- Human histone deacetylase 6 shows strong preference for tubulin dimers over assembled microtubules
- (2017) Lubica Skultetyova et al. Scientific Reports
- Multitarget Drugs: an Epigenetic Epiphany
- (2016) A. Ganesan ChemMedChem
- Be aware of error measures. Further studies on validation of predictive QSAR models
- (2016) Kunal Roy et al. CHEMOMETRICS AND INTELLIGENT LABORATORY SYSTEMS
- Inside HDACs with more selective HDAC inhibitors
- (2016) Joëlle Roche et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Targeting histone deacetylases in T-cell lymphoma
- (2016) Alison J. Moskowitz et al. LEUKEMIA & LYMPHOMA
- Histone deacetylase 6 structure and molecular basis of catalysis and inhibition
- (2016) Yang Hai et al. Nature Chemical Biology
- Evaluation of histone deacetylase inhibitors (HDACi) as therapeutic leads for human African trypanosomiasis (HAT)
- (2015) Angela K. Carrillo et al. BIOORGANIC & MEDICINAL CHEMISTRY
- Identification of HDAC6-Selective Inhibitors of Low Cancer Cell Cytotoxicity
- (2015) Irina N. Gaisina et al. ChemMedChem
- On a simple approach for determining applicability domain of QSAR models
- (2015) Kunal Roy et al. CHEMOMETRICS AND INTELLIGENT LABORATORY SYSTEMS
- Beware of R2: Simple, Unambiguous Assessment of the Prediction Accuracy of QSAR and QSPR Models
- (2015) D. L. J. Alexander et al. Journal of Chemical Information and Modeling
- Histone deacetylases and their inhibitors in cancer, neurological diseases and immune disorders
- (2014) Katrina J. Falkenberg et al. NATURE REVIEWS DRUG DISCOVERY
- 50 years of protein acetylation: from gene regulation to epigenetics, metabolism and beyond
- (2014) Eric Verdin et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- Development and Therapeutic Implications of Selective Histone Deacetylase 6 Inhibitors
- (2013) Jay H. Kalin et al. JOURNAL OF MEDICINAL CHEMISTRY
- The 'rule of three' for fragment-based drug discovery: where are we now?
- (2013) Harren Jhoti et al. NATURE REVIEWS DRUG DISCOVERY
- A Selective HDAC 1/2 Inhibitor Modulates Chromatin and Gene Expression in Brain and Alters Mouse Behavior in Two Mood-Related Tests
- (2013) Frederick A. Schroeder et al. PLoS One
- Development of a histone deacetylase 6 inhibitor and its biological effects
- (2013) J.-H. Lee et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Histone Deacetylase 4 (HDAC4) Inhibitors: A Promising Treatment for Huntington’s Disease
- (2013) Ahmed F. Abdel-Magid ACS Medicinal Chemistry Letters
- Development of a Chimeric c-Src Kinase and HDAC Inhibitor
- (2013) Kristin S. Ko et al. ACS Medicinal Chemistry Letters
- Molecular interaction fields in drug discovery: recent advances and future perspectives
- (2013) Anna Artese et al. Wiley Interdisciplinary Reviews-Computational Molecular Science
- Selective Histone Deacetylase 6 Inhibitors Bearing Substituted Urea Linkers Inhibit Melanoma Cell Growth
- (2012) Joel A. Bergman et al. JOURNAL OF MEDICINAL CHEMISTRY
- Epigenetic protein families: a new frontier for drug discovery
- (2012) Cheryl H. Arrowsmith et al. NATURE REVIEWS DRUG DISCOVERY
- Discovery of (2E)-3-{2-Butyl-1-[2-(diethylamino)ethyl]-1H-benzimidazol-5-yl}-N-hydroxyacrylamide (SB939), an Orally Active Histone Deacetylase Inhibitor with a Superior Preclinical Profile
- (2011) Haishan Wang et al. JOURNAL OF MEDICINAL CHEMISTRY
- Histone deacetylase inhibitors: A chemical genetics approach to understanding cellular functions
- (2010) Paul A. Marks Biochimica et Biophysica Acta-Gene Regulatory Mechanisms
- Acylurea connected straight chain hydroxamates as novel histone deacetylase inhibitors: Synthesis, SAR, and in vivo antitumor activity
- (2010) Haishan Wang et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- The Role of HDAC6 in Cancer
- (2010) Grace I. Aldana-Masangkay et al. JOURNAL OF BIOMEDICINE AND BIOTECHNOLOGY
- Rational Design and Simple Chemistry Yield a Superior, Neuroprotective HDAC6 Inhibitor, Tubastatin A
- (2010) Kyle V. Butler et al. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
- Chemical phylogenetics of histone deacetylases
- (2010) James E Bradner et al. Nature Chemical Biology
- N-Hydroxy-1,2-disubstituted-1H-benzimidazol-5-yl acrylamides as novel histone deacetylase inhibitors: Design, synthesis, SAR studies, and in vivo antitumor activity
- (2009) Haishan Wang et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Development of a fluorescence polarization based assay for histone deacetylase ligand discovery
- (2008) Ralph Mazitschek et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Role of the Aggresome Pathway in Cancer: Targeting Histone Deacetylase 6-Dependent Protein Degradation
- (2008) A. Rodriguez-Gonzalez et al. CANCER RESEARCH
- Histone Modifications and Nuclear Architecture: A Review
- (2008) Eva Bártová et al. JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY
- Structural Origin of Selectivity in Class II-Selective Histone Deacetylase Inhibitors
- (2008) Guillermina Estiu et al. JOURNAL OF MEDICINAL CHEMISTRY
- The many roles of histone deacetylases in development and physiology: implications for disease and therapy
- (2008) Michael Haberland et al. NATURE REVIEWS GENETICS
- The Rpd3/Hda1 family of lysine deacetylases: from bacteria and yeast to mice and men
- (2008) Xiang-Jiao Yang et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- Class II-selective histone deacetylase inhibitors. Part 2: Alignment-independent GRIND 3-D QSAR, homology and docking studies
- (2007) Rino Ragno et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now